Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · March 21, 2013

Biomarkers uPA and PAI-1 for Therapy Decisions in Node-Negative Breast Cancer

European Journal of Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Journal of Cancer
Ten-Year Analysis of the Prospective Multicentre Chemo-N0 Trial Validates American Society of Clinical Oncology (ASCO)-Recommended Biomarkers uPA and PAI-1 for Therapy Decision Making in Node-Negative Breast Cancer Patients
Eur. J. Cancer 2013 Mar 13;[EPub Ahead of Print], N Harbeck, M Schmitt, C Meisner, et al

Further Reading